Esmolol Hydrochloride Double Strength in Plastic Container
Esmolol hydrochloride is available in a double strength formulation and is supplied in a plastic container [1].
What is Esmolol Hydrochloride Used For?
Esmolol hydrochloride is a beta-adrenergic receptor blocker used for the rapid control of heart rate in patients with atrial fibrillation or atrial flutter [1]. It is also indicated for the treatment of supraventricular tachycardia and for controlling heart rate and blood pressure during and after cardiac surgery [1].
Why is Esmolol Hydrochloride Supplied in a Plastic Container?
The use of plastic containers for Esmolol hydrochloride offers several advantages, including reduced risk of breakage compared to glass [2].
What are the Available Strengths of Esmolol Hydrochloride?
Esmolol hydrochloride is available in multiple strengths, including a double strength formulation, typically for intravenous administration [1]. Specific concentrations can vary by manufacturer.
When Does Esmolol Hydrochloride's Patent Protection End?
Information regarding the specific patent expiration for Esmolol hydrochloride and its various formulations, including double strength in plastic containers, can be found on DrugPatentWatch.com [3]. Patent information is crucial for understanding when generic versions may become available.
Who Manufactures Esmolol Hydrochloride?
Several pharmaceutical companies manufacture Esmolol hydrochloride. Specific manufacturers and their product offerings, including formulations in plastic containers, can be identified through drug databases and resources like DrugPatentWatch.com [3].
What is the Difference Between Esmolol and Other Beta-Blockers?
Esmolol is an ultra-short-acting beta-1 selective adrenergic receptor inhibitor. Its short duration of action, due to rapid metabolism by plasma and tissue esterases, allows for precise titration and rapid reversal of effects when discontinued, which is beneficial in critical care settings [1]. This differentiates it from longer-acting beta-blockers used for chronic conditions [4].
How is Esmolol Hydrochloride Administered?
Esmolol hydrochloride is administered intravenously, usually as a continuous infusion [1]. Dosing is carefully titrated based on patient response and clinical condition.
What are the Risks Associated with Esmolol Hydrochloride?
Potential risks and side effects include bradycardia, hypotension, heart failure, bronchospasm, and hyperglycemia [1]. Close monitoring of vital signs and cardiac rhythm is essential during administration.
Where Can I Find More Information on Esmolol Hydrochloride Patents?
Detailed information on patents related to Esmolol hydrochloride, including exclusivity periods and potential challenges, is available at DrugPatentWatch.com [3]. This resource can help track the lifecycle of the drug's intellectual property.
Can Generic Esmolol Hydrochloride Be Made Available?
The availability of generic Esmolol hydrochloride is directly tied to the expiration of its patents and any applicable market exclusivities. Resources like DrugPatentWatch.com track these timelines [3].
Sources:
[1] Information on Esmolol Hydrochloride formulation and use.
[2] General benefits of plastic containers in pharmaceutical packaging.
[3] DrugPatentWatch.com - Esmolol Hydrochloride patent information.
[4] Information on beta-blocker pharmacokinetics.